Menu
Search
|

Menu

Close
X

Bayer AG BAYGN.DE (Xetra)

66.64 EUR
-1.97 (-2.87%)
As of 11:35 AM EST
chart
Previous Close 68.61
Open 68.48
Volume 5,904,875
3m Avg Volume 3,762,807
Today’s High 70.43
Today’s Low 65.75
52 Week High 108.55
52 Week Low 64.83
Shares Outstanding (mil) 932.55
Market Capitalization (mil) 63,982.39
Forward P/E 17.72
Dividend (Yield %) 2.76 ( 4.02 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.81 Mean rating from 26 analysts

KEY STATS

Revenue (mm, EUR)
FY18
18,619
FY17
35,015
FY16
40,768
FY15
46,085
EPS (EUR)
FY18
3.076
FY17
3.439
FY16
4.791
FY15
4.790
*Note: Units in Millions of Euro
**Note: Units in Euro

KEY RATIOS

Price to Earnings (TTM)
vs sector
17.72
29.57
Price to Sales (TTM)
vs sector
1.82
15.43
Price to Book (MRQ)
vs sector
1.36
4.06
Price to Cash Flow (TTM)
vs sector
10.62
21.23
Total Debt to Equity (MRQ)
vs sector
110.57
14.84
LT Debt to Equity (MRQ)
vs sector
90.34
11.13
Return on Investment (TTM)
vs sector
4.06
12.77
Return on Equity (TTM)
vs sector
8.67
14.47

EXECUTIVE LEADERSHIP

Werner Wenning
Independent Chairman of the Supervisory Board, Since 2012
Salary: €360,000.00
Bonus: --
Werner Baumann
Chairman of the Management Board, Chief Executive Officer, Since 2016
Salary: €1,487,000.00
Bonus: €49,000.00
Oliver Zuehlke
Independent Vice Chairman of the Supervisory Board, Employee Representative, Since 2015
Salary: €240,000.00
Bonus: --
Hartmut Klusik
Member of the Management Board, Director of Human Resources, Technology & Sustainability, Labor Director, Since 2016
Salary: €756,000.00
Bonus: €40,000.00
Jennifer Brendelto
Vice President - Communications of the Consumer Health Division, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

Kaiser-Wilhelm-Allee 1
LEVERKUSEN     51373

Phone: +49214.301

Bayer AG is a life science company. The Company's segments are Pharmaceuticals, Consumer Health, Crop Science and Animal Health. The Pharmaceuticals segment focuses on researching, developing and marketing prescription products and specialty therapeutics especially in the areas of cardiology, oncology, gynecology, hematology and ophthalmology, as well as radiopharmacology and others. The Consumer Health segment develops, produces and markets nonprescription over-the-counter products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories, among others. The Crop Science segment researches, develops and markets crop protection solutions and seeds, and includes the subsidiary Monsanto. The Animal Health segment is engaged in the development, production and marketing of prescription and nonprescription veterinary products.

SPONSORED STORIES